Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | BTN3A1 | O00481 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | WRN | Q14191 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | MGAM | O43451 | 2/20 | 0.30 |
| ▸ | GAA | P10253 | 2/20 | 0.30 |
| ▸ | SI | P14410 | 2/20 | 0.30 |
| ▸ | MGAM2 | Q2M2H8 | 2/20 | 0.30 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6765418 | 1.00 | NAAA (0.36) | NAAAALDH1A1TDP1BTN3A1CYP1A2 | |
| SCHEMBL1685651 | 0.80 | ALDH1A1 (0.44) | NAAAALDH1A1TDP1BTN3A1CYP1A2 | |
| SCHEMBL7848629 | 0.80 | ALDH1A1 (0.48) | ALDH1A1TDP1BTN3A1HPGDALOX15 | |
| SCHEMBL3137231 | 0.80 | ALDH1A1 (0.48) | ALDH1A1TDP1BTN3A1HPGDALOX15 | |
| SCHEMBL3137233 | 0.80 | ALDH1A1 (0.48) | ALDH1A1TDP1BTN3A1HPGDALOX15 | |
| SCHEMBL3659692 | 0.78 | ALDH1A1 (0.42) | NAAAALDH1A1TDP1CYP1A2HPGD | |
| SCHEMBL6768507 | 0.78 | TSHR (0.60) | ALDH1A1TSHRLMNA | |
| SCHEMBL6768508 | 0.78 | TSHR (0.60) | ALDH1A1TSHRLMNA | |
| SCHEMBL17865596 | 0.75 | ALDH1A1 (0.40) | NAAAALDH1A1CYP1A2HPGDCYP2C19 | |
| SCHEMBL17865597 | 0.75 | ALDH1A1 (0.40) | NAAAALDH1A1CYP1A2HPGDCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12479814-B2 | Process for production of new sulfolenic intermediates | DSM IP ASSETS B.V. (NL) | 2025-11-25 | — | — | US | disclosed |
| US-12410117-B2 | Process for production of vitamin A | DSM IP ASSETS B.V. (NL) | 2025-09-09 | — | — | US | disclosed |
| EP-4126838-B1 | PROCESS FOR PRODUCTION OF VITAMIN A | DSM IP ASSETS BV (NL) | 2024-03-13 | — | — | EP | disclosed |
| US-20230142429-A1 | PROCESS FOR PRODUCTION OF NEW SULFOLENIC INTERMEDIATES | DSM IP ASSETS B.V. (NL) | 2023-05-11 | — | — | US | disclosed |
| US-20230125156-A1 | PROCESS FOR PRODUCTION OF VITAMIN A | DSM IP ASSETS B.V. (NL) | 2023-04-27 | — | — | US | disclosed |
| EP-4126837-A1 | PROCESS FOR PRODUCTION OF NEW SULFOLENIC INTERMEDIATES | DSM IP Assets B.V. (NL) | 2023-02-08 | — | — | EP | disclosed |
| EP-4126838-A1 | PROCESS FOR PRODUCTION OF VITAMIN A | DSM IP Assets B.V. (NL) | 2023-02-08 | — | — | EP | disclosed |
| CN-115515945-A | Process for the preparation of novel sulfone intermediates | 帝斯曼知识产权资产管理有限公司 | 2022-12-23 | — | — | CN | disclosed |
| CN-115348960-A | Process for the preparation of vitamin A | 帝斯曼知识产权资产管理有限公司 | 2022-11-15 | — | — | CN | disclosed |
| WO-2021197889-A1 | PROCESS FOR PRODUCTION OF NEW SULFOLENIC INTERMEDIATES | DSM IP ASSETS B.V. (NL) | 2021-10-07 | — | — | WO | disclosed |
| WO-2021197890-A1 | PROCESS FOR PRODUCTION OF VITAMIN A | DSM IP ASSETS B.V. (NL) | 2021-10-07 | — | — | WO | disclosed |
| US-6727381-B2 | REACTING PHOSPHONATE COMPOUND WITH ALDEHYDE IN ORGANIC SOLVENT (HEXANE) IN PRESENCE OF A BASE (SODIUM TERT-BUTOXIDE) | ZHEJIANG MEDICINE CO., LTD., XINCHANG PHARMACEUTICAL FACTORY (CN) | 2004-04-27 | — | — | US | disclosed |
| US-20020151742-A1 | Process for producing vitamin a ester | ZHEJIANG MEDICINE CO., LTD. (CN) | 2002-10-17 | — | — | US | disclosed |
| US-5424478-A | Process for producing vitamin A derivatives | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1995-06-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12410117-B2 | Process for production of vitamin A | TTPA, ADH4, ADH1B | NAAA 180/4885ALDH1A1 279/4885TDP1 4375/4885 |
| US-12479814-B2 | Process for production of new sulfolenic intermediates | FASN, ADH1B, COASY | NAAA 268/4885ALDH1A1 427/4885TDP1 4796/4885 |
| US-20230142429-A1 | PROCESS FOR PRODUCTION OF NEW SULFOLENIC INTERMEDIATES | FASN, ADH1B, COASY | NAAA 268/4885ALDH1A1 427/4885TDP1 4796/4885 |
| US-20230125156-A1 | PROCESS FOR PRODUCTION OF VITAMIN A | TTPA, ADH4, ADH1B | NAAA 180/4885ALDH1A1 279/4885TDP1 4375/4885 |
| US-20020151742-A1 | Process for producing vitamin a ester | TTPA, ADH1B, ADH4 | NAAA 117/4885ALDH1A1 13/4885TDP1 2062/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.